The Shareholders Foundation announced that a deadline is coming up on January 9, 2017 in the lawsuit filed for certain investors in NASDAQ:DNAI shares over alleged securities laws violations by ProNAi Therapeutics Inc. Investors who purchased shares of ProNAi Therapeutics Inc (NASDAQ:DNAI) have certain options and there are strict and short deadlines running. Deadline: January […]
Abeona Therapeutics Inc (NASDAQ:ABEO) Investor Alert: Lawsuit alleges Misleading Statements
An investor in NASDAQ:ABEO shares filed a lawsuit in t New York over alleged violations of Federal Securities Laws by Abeona Therapeutics in connection with certain allegedly false and misleading statements made. Investors who purchased shares of Abeona Therapeutics Inc (NASDAQ:ABEO) have certain options and for certain investors are short and strict deadlines running. Deadline: […]
NASDAQ:AKBA Investor News: Lawsuit alleges Misleading Statements by Akebia Therapeutics Inc
The Shareholders Foundation announced that an investor in NASDAQ:AKBA shares filed a lawsuit in Massachusetts over alleged violations of Securities Laws by Akebia Therapeutics Inc in connection with certain allegedly false and misleading statements. If you purchased shares of Akebia Therapeutics Inc (NASDAQ:AKBA) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or […]
NASDAQ:FOLD Investor News: Investigation over potential Wrongdoing at Amicus Therapeutics, Inc.
An investigation for investors in Amicus Therapeutics shares was announced concerning possible breaches of fiduciary duties by certain directors at Amicus Therapeutics. Investors who purchased shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 – 1554. The investigation by a law firm concerns […]
NASDAQ:DNAI Investor News: Lawsuit alleges Misleading Statements by ProNAi Therapeutics Inc
An investor in NASDAQ:DNAI shares, filed a lawsuit over alleged violations of Federal Securities Laws by ProNAi Therapeutics Inc in connection with certain allegedly false and misleading statements. Investors who purchased shares of ProNAi Therapeutics Inc (NASDAQ:DNAI) have certain options and for certain investors are short and strict deadlines running. Deadline: January 9, 2017. NASDAQ:DNAI […]
Investor News: Investigation of potential Wrongdoing at Seres Therapeutics Inc (NASDAQ:MCRB)
An investigation was announced for investors in NASDAQ:MCRB shares concerning potential breaches of fiduciary duties by certain directors of Seres Therapeutics. Investors who are current long term investors in Seres Therapeutics Inc (NASDAQ:MCRB) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 – 1554. The investigation by a […]
- « Previous Page
- 1
- 2
- 3
- 4
- 5
- 6
- …
- 38
- Next Page »